Search Results - "Malcolm, W.A"

An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom by Malcolm, W.A, Claxton, L, Hodgson, R, Taylor, M

Get full text

Bayesian mixed treatment comparison (MTC): A novel method to demonstrate equivalence and non-inferiority by Malcolm, W.A, Uthman, O.A

Get full text

A Comparison of Modelling Techniques: Patient Simulation Verse Markov Modelling in Ophthalmology by Claxton, L, Malcolm, W.A, Hodgson, R

Get full text

Indirect treatment comparison of interventions for Neovascular (WET) age-related macular degeneration (WET AMD) by Malcolm, W.A, Hodgson, R, Glanville, J, Barata, T, Fleetwood, K

Get full text

Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom by Leteneux, C, Claxton, L, Malcolm, W.A, Taylor, M, Rathi, H

Get full text

The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia by Malcolm, W.A, Leteneux, C, Claxton, L, Taylor, M, Rathi, H

Get full text

PRM203 - Bayesian mixed treatment comparison (MTC): A novel method to demonstrate equivalence and non-inferiority by Malcolm, W.A., Uthman, O.A.

Get full text

PRM90 - A Comparison of Modelling Techniques: Patient Simulation Verse Markov Modelling in Ophthalmology by Claxton, L., Malcolm, W.A., Hodgson, R.

Get full text

PSS2 - Indirect treatment comparison of interventions for Neovascular (WET) age-related macular degeneration (WET AMD) by Malcolm, W.A., Hodgson, R., Glanville, J., Barata, T., Fleetwood, K.

Get full text

PSS25 - An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom by Malcolm, W.A., Claxton, L., Hodgson, R., Taylor, M.

Get full text

PSS22 - Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom by Leteneux, C., Claxton, L., Malcolm, W.A., Taylor, M., Rathi, H.

Get full text

PSS9 - The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia by Malcolm, W.A., Leteneux, C., Claxton, L., Taylor, M., Rathi, H.

Get full text